Schinzari, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.841
EU - Europa 1.651
AS - Asia 287
AF - Africa 38
OC - Oceania 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.839
Nazione #
US - Stati Uniti d'America 1.833
SE - Svezia 459
DE - Germania 425
IT - Italia 228
CN - Cina 172
IE - Irlanda 135
FR - Francia 87
UA - Ucraina 68
BE - Belgio 61
GB - Regno Unito 59
PL - Polonia 53
IN - India 52
CI - Costa d'Avorio 38
FI - Finlandia 31
TR - Turchia 20
IR - Iran 16
AU - Australia 11
RO - Romania 11
CZ - Repubblica Ceca 8
HK - Hong Kong 8
CA - Canada 7
JP - Giappone 5
NL - Olanda 5
CH - Svizzera 4
PE - Perù 4
SG - Singapore 4
AT - Austria 3
ES - Italia 3
EU - Europa 3
GR - Grecia 3
NO - Norvegia 3
CY - Cipro 2
PK - Pakistan 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 3.839
Città #
Chandler 481
Ashburn 139
Dublin 135
New York 85
Wilmington 66
San Mateo 63
Brussels 61
Fairfield 56
Ann Arbor 55
Warsaw 52
Princeton 46
Nanjing 44
Jacksonville 42
Marseille 39
Abidjan 38
Boston 38
Dearborn 35
Cattolica 33
Milan 32
Rome 29
Redwood City 26
Seattle 26
Nürnberg 25
Woodbridge 25
Cambridge 24
Redmond 24
Beijing 21
Bremen 20
Houston 20
Izmir 17
Nanchang 17
Falls Church 14
Helsinki 13
Hebei 12
London 12
Shanghai 12
Augusta 11
Norwalk 11
Lawrence 10
Leawood 10
Changsha 8
Washington 8
Kish 7
Mountain View 7
Hong Kong 6
Jiaxing 6
Kunming 6
Paris 6
Shenyang 6
Andover 5
Bari 5
Boydton 5
Edinburgh 5
Fremont 5
Guangzhou 5
Pune 5
San Diego 5
Boardman 4
Chicago 4
Hangzhou 4
Hefei 4
Lappeenranta 4
Lima 4
Los Angeles 4
Munich 4
Sydney 4
Tokyo 4
University Park 4
Winston Salem 4
Ardea 3
Berlin 3
Brno 3
Chiswick 3
Detroit 3
Florence 3
Gunzenhausen 3
Hounslow 3
Kashan 3
Lanzhou 3
Lanzo d'Intelvi 3
Northbrook 3
Prague 3
Seelze 3
Somma Vesuviana 3
Tianjin 3
Vienna 3
Acquaviva delle Fonti 2
Amsterdam 2
Atlanta 2
Bern 2
Bologna 2
Brdo 2
Burlington 2
Changchun 2
Clearwater 2
Dong Ket 2
Duncan 2
Falkenstein 2
Garden City 2
Giovinazzo 2
Totale 2.146
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 261
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 176
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 127
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 124
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 122
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 103
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 102
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 100
Are TKIs favourable for the elderly with non-small-cell lung cancer? 100
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 91
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 81
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 79
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 79
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 76
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 71
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 70
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 69
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 66
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 64
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 64
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 62
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 61
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 57
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 56
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 55
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 55
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 55
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 55
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 54
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 53
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 53
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 52
Skin cancer triage and management during COVID-19 pandemic. 50
Methylation study of the Paris system for reporting urinary (TPS) categories 50
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 50
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 49
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 49
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 48
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 48
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 47
Biomarkers of response to advanced prostate cancer therapy 47
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 45
Efficacy of immune checkpoint inhibitors in different types of melanoma 45
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 45
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 44
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 43
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 41
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 41
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 40
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 36
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 35
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 33
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 32
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 32
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 32
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 26
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 26
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 23
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 23
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 22
Targeted therapy in advanced gastric carcinoma: The future is beginning 21
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 21
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 19
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 15
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 13
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 12
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 12
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 9
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 8
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 6
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 1
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 1
Totale 3.933
Categoria #
all - tutte 16.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201980 0 0 0 0 0 0 0 0 10 26 31 13
2019/2020503 91 30 26 58 42 35 73 13 24 22 70 19
2020/2021246 10 19 8 15 30 9 33 9 31 28 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.416 181 178 100 226 57 158 112 124 147 43 60 30
2023/2024580 41 194 52 50 33 111 52 33 14 0 0 0
Totale 3.933